Prognostic determinants in epithelioid sarcoma

European Journal of Cancer

Volumn 47, Issue 2, 2011, Pages 287-295

  Gasparini, Patrizia ^a   Facchinetti, Federica ^a   Boeri, Mattia ^a   Lorenzetto, Erica ^b   Livio, Anna ^a   Gronchi, Alessandro ^a   Ferrari, Andrea ^a   Massimino, Maura ^a   Spreafico, Filippo ^a   Giangaspero, Felice ^c,d   Forni, Marco ^e   Maestro, Roberta ^b   Alaggio, Rita ^f   Pilotti, Silvana ^a   Collini, Paola ^a   Modena, Piergiorgio ^b   Sozzi, Gabriella ^a  

^a NATIONAL CANCER INSTITUTE   (Italy)

^b CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

^d IRCCS NEUROMED   (Italy)

^e REGINA MARGHERITA CHILDREN S HOSPITAL   (Italy)

^f UNIVERSITY OF PADOVA   (Italy)

Author keywords

Epithelioid sarcoma; INI1; Malignant rhabdoid tumour; Sarcoma; SMARCB1

Indexed keywords

PROTEIN; PROTEIN SMARCB1; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER GRADING; CHILD; CORRELATION ANALYSIS; DISEASE COURSE; EPITHELIOID SARCOMA; FEMALE; GENE DELETION; GENE INACTIVATION; GENE MUTATION; HUMAN; IMMUNOPHENOTYPING; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SURVIVAL RATE; TUMOR SUPPRESSOR GENE;

ADOLESCENT; ADULT; AGED; CHILD; CHROMOSOMAL PROTEINS, NON-HISTONE; DNA-BINDING PROTEINS; EXTREMITIES; GASTROINTESTINAL STROMAL TUMORS; GENES, TUMOR SUPPRESSOR; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; KAPLAN-MEIER ESTIMATE; MIDDLE AGED; MUTATION; PROGNOSIS; RHABDOID TUMOR; SARCOMA; TRANSCRIPTION FACTORS; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 78650688073     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2010.09.003     Document Type: Article

References (24)

1. C.C.D. Fletcher, K.K. Unni, F. Mertens, Pathology and genetics of tumors of soft tissue and bone 2002 IARC Press Lyon
2. A.P. Dei Tos, A.J. Wagner, P. Modena, A. Comandone, and S. Leyvraz Epithelioid soft tissue tumors Semin Oncol 36 4 2009 347 357
3. M. Casanova, A. Ferrari, and P. Collini Epithelioid sarcoma in children and adolescents: a report from the Italian Soft Tissue Sarcoma Committee Cancer 106 3 2006 708 717
4. P. Modena, E. Lualdi, and F. Facchinetti SMARCB1/INI1 tumor suppressor gene is frequently inactivated in epithelioid sarcomas Cancer Res 65 10 2005 4012 4019
5. I. Versteege, N. Sevenet, and J. Lange Truncating mutations of hSNF5/INI1 in aggressive paediatric cancer Nature 394 6689 1998 203 206
6. J.A. Biegel, J.Y. Zhou, and L.B. Rorke Germ-line and acquired mutations of INI1 in atypical teratoid and rhabdoid tumors Cancer Res 59 1 1999 74 79
7. D. Alarcon-Vargas, Z. Zhang, and B. Agarwal Targeting Cyclin D1, a downstream effector of INI1/hSNF5, in rhabdoid tumors Oncogene 25 5 2006 722 734
8. M.E. Smith, V. Cimica, and S. Chinni Rhabdoid tumor growth is inhibited by flavopiridol Clin Cancer Res 14 2 2008 523 532
9. Biegel JA, Zhou JY, Rorke LB, et al. Germ-line and acquired mutations of INI1 in atypical teratoid and rhabdoid tumors. Cancer Res 1999;59(1):74-9.
10. L. Guillou, J.M. Coindre, and F. Bonichon Comparative study of the National Cancer Institute and French Federation of Cancer Centers Sarcoma Group grading systems in a population of 410 adult patients with soft tissue sarcoma J Clin Oncol 15 1 1997 350 362
11. D. Baratti, E. Pennacchioli, and P.G. Casali Epithelioid sarcoma: prognostic factors and survival in a series of patients treated at a single institution Ann Surg Oncol 14 12 2007 3542 3551 (Pubitemid 350160144)
12. E. Lualdi, P. Modena, and M. Debiec-Rychter Molecular cytogenetic characterization of proximal-type epithelioid sarcoma Genes Chromosomes Cancer 41 3 2004 283 290
13. L. Chbani, L. Guillou, and P. Terrier Epithelioid sarcoma: a clinicopathologic and immunohistochemical analysis of 106 cases from the French sarcoma group Am J Clin Pathol 131 2 2009 222 227
14. J.L. Hornick, P. Dal Cin, and C.D. Fletcher Loss of INI1 expression is characteristic of both conventional and proximal-type epithelioid sarcoma Am J Surg Pathol 33 4 2009 542 550
15. D. Raoux, M. Peoc'h, and F. Pedeutour Primary epithelioid sarcoma of bone: report of a unique case, with immunohistochemical and fluorescent in situ hybridization confirmation of INI1 deletion Am J Surg Pathol 33 6 2009 954 958
16. K. Kohashi, T. Izumi, and Y. Oda Infrequent SMARCB1/INI1 gene alteration in epithelioid sarcoma: a useful tool in distinguishing epithelioid sarcoma from malignant rhabdoid tumor Human Pathol 40 3 2009 349 355
17. U. Flucke, P.J. Slootweg, T. Mentzel, P. Pauwels, and T.J. Hulsebos Re: Infrequent SMARCB1/INI1 gene alteration in epithelioid sarcoma: a useful tool in distinguishing epithelioid sarcoma from malignant rhabdoid tumor: direct evidence of mutational inactivation of SMARCB1/INI1 in epithelioid sarcoma Human Pathol 40 9 2009 1361 1362
18. J.P. Schouten, C.J. McElgunn, and R. Waaijer Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification Nucleic Acids Res 30 12 2002 e57
19. C. Fisher Epithelioid sarcoma of Enzinger Adv Anat Pathol 13 3 2006 114 121
20. T. Izumi, Y. Oda, and T. Hasegawa Prognostic significance of dysadherin expression in epithelioid sarcoma and its diagnostic utility in distinguishing epithelioid sarcoma from malignant rhabdoid tumor Mod Pathol 19 6 2006 820 831
21. H. Lin, R.P. Wong, M. Martinka, and G. Li Loss of SNF5 expression correlates with poor patient survival in melanoma Clin Cancer Res 15 20 2009 6404 6411
22. R.G. Vries, V. Bezrookove, and L.M. Zuijderduijn Cancer-associated mutations in chromatin remodeler hSNF5 promote chromosomal instability by compromising the mitotic checkpoint Genes Dev 19 6 2005 665 670
23. A.N. Imbalzano, and S.N. Jones Snf5 tumor suppressor couples chromatin remodeling, checkpoint control, and chromosomal stability Cancer Cell 7 4 2005 294 295
24. M. Tsikitis, Z. Zhang, W. Edelman, D. Zagzag, and G.V. Kalpana Genetic ablation of Cyclin D1 abrogates genesis of rhabdoid tumors resulting from Ini1 loss Proc Natl Acad Sci USA 102 34 2005 12129 12134